Aflibercept Plus FOLFIRI as Second-Line Treatment for Metastatic Colorectal Cancer: A Single-Institution Real-Life Experience

SIMPLE SUMMARY: The continuum of care for mCRC might include anti-angiogenic drug as anti-VEGF/VEGFR moAb and recombinant proteins in combination with fluoropyrimidine-based regimens in first- and second-line treatment, and multikinase inhibitors in refractory patients. The addition of aflibercept t...

Descripción completa

Detalles Bibliográficos
Autores principales: Lavacchi, Daniele, Roviello, Giandomenico, Giommoni, Elisa, Dreoni, Lorenzo, Derio, Silvia, Brugia, Marco, Amedei, Amedeo, Pillozzi, Serena, Antonuzzo, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345481/
https://www.ncbi.nlm.nih.gov/pubmed/34359764
http://dx.doi.org/10.3390/cancers13153863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345481/
https://www.ncbi.nlm.nih.gov/pubmed/34359764
http://dx.doi.org/10.3390/cancers13153863

Ejemplares similares